Blog Post

February 12, 2024

ReAlta CEO and CFO Attending Oppenheimer Healthcare Life Sciences Conference February 13-14, 2024

ReAlta’s CEO Ulrich Thienel and CFO John Rickman are attending the 34th Annual Oppenheimer & Co. Inc. Healthcare Life Sciences Conference February 13-14th, where they are meeting with investors to discuss our latest program developments, including updates on our three Phase 2 clinical trials for hypoxic-ischemic encephalopathy (HIE), acute graft-versus-host disease (GvHD) and acute exacerbations of COPD. Dr. Thienel will be presenting an overview of the company’s platform technology at 2:00pm EST on Tuesday, February 13, 2024.


Oct 26, 2020

Facility Tours

Dr. Neel Krishna and Dr. Katherine LaVallee, DVM did an outstanding job leading tours of our lab and offices last...

Read More
Oct 21, 2020

New ReAlta Headquarters

We want to thank Rep. Elaine Luria and Norfolk Mayor Dr. Kenneth Alexander for helping us celebrate the official opening...

Read More
Apr 30, 2021

HIE Awareness Month

ReAlta Life Sciences is officially part of Team Hope! We are extending our gratitude to the Hope for HIE team...

Read More